Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nalidixic acid-induced photodermatitis after minimal sun exposure

A Boisvert, G Barbeau

    Drug Intelligence & Clinical Pharmacy
    |February 1, 1981
    PubMed
    Summary

    Nalidixic acid can cause bullous photodermatitis, a severe skin reaction triggered by sunlight. This allergic reaction, characterized by blistering and redness, can persist for weeks and reappear with sun exposure.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Metallosis following hip arthroplasty: two case reports.

    Journal of medical case reports·2022
    Same author

    Predictors of improvement in left ventricular function after percutaneous revascularization of occluded coronary arteries: a report from the Total Occlusion Study of Canada (TOSCA).

    American heart journal·2001
    Same author

    Primary stenting versus balloon angioplasty in occluded coronary arteries: the Total Occlusion Study of Canada (TOSCA).

    Circulation·1999
    Same author

    Clinical outcomes of patients more than one year following randomization in the Canadian Coronary Atherectomy Trial (CCAT).

    The Canadian journal of cardiology·1997
    Same author

    Use of ribotyping to distinguish Bordetella bronchiseptica isolates.

    International journal of systematic bacteriology·1997
    Same author

    A comparison of directional atherectomy with balloon angioplasty for lesions of the left anterior descending coronary artery.

    The New England journal of medicine·1993

    Area of Science:

    • Dermatology
    • Pharmacology
    • Toxicology

    Background:

    • Nalidixic acid is an antibiotic with known photosensitizing potential.
    • Bullous photodermatitis is a rare but severe adverse drug reaction.
    • Over 30 cases of this reaction linked to nalidixic acid have been documented.

    Observation:

    • A 57-year-old woman developed bullous photodermatitis despite minimal sun exposure.
    • The reaction primarily affected the dorsal hands, feet, and legs, sparing the face.
    • Blistering was a consistent feature, accompanied by common erythema.

    Findings:

    • Nalidixic acid-induced photoreactions predominantly affect females.
    • The onset and severity appear independent of dosage regimen and treatment duration.
    • The reaction is likely allergic in nature, with prolonged duration (3-6 weeks).

    Implications:

    • Recurrence of blistering can occur for months upon reexposure to sunlight, even without drug rechallenge.
    • Clinicians should be aware of this potential adverse effect when prescribing nalidixic acid.
    • Patient education regarding sun avoidance is crucial for those treated with nalidixic acid.

    Related Experiment Videos